Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

PRE-REGISTER

Program Chairs

April Armstrong, MD, MPH
Keck School of Medicine, USC
Studio City, California, United States

Dr. April Armstrong is Associate Dean at Keck School of Medicine of the University of Southern California (USC). She also serves as Director of Clinical Research Support at the Southern California Clinical and Translational Science Institute (CTSI). Dr. Armstrong also serves as Vice Chair and Director of Psoriasis Program in the dermatology department at USC. Dr. Armstrong obtained her MD and completed dermatology residency at Harvard. She also obtained a MPH in Clinical Effectiveness from Harvard School of Public Health. Dr. Armstrong is highly committed to clinical research and the care of patients with inflammatory skin diseases such as psoriasis and atopic dermatitis. Her research in focuses on (1) investigating comorbidities related to psoriasis and atopic dermatitis, (2) identifying treatment patterns, treatment goals, and economic burden of inflammatory skin disease, and (3) increasing patient access using innovative, technology-enabled healthcare delivery methods. She has conducted over 100 clinical trials and published over 210 articles in scientific journals. She holds multiple leadership positions at professional societies, including the National Psoriasis Foundation, Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Psoriasis Council, and the American Academy of Dermatology. She is an associate Editor for JAMA Dermatology and has also served on the editorial boards of JAAD and Telemedicine and eHealth.

Last Updated: Jul 31, 2019

Johann Gudjonsson, MD, PhD
University of Michigan
Ann Arbor, Michigan, United States

Dr. Gudjonsson is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute and an Associate Prof. and Director of Inpatient Consultation and Dermatology at the University of Michigan, Ann Arbor.

Last Updated: Sep 18, 2018

Nehal Mehta, MD, MSCE, FAHA
National Heart, Lung and Blood Institute
Bethesda, Maryland, United States

Nehal Mehta attended an accelerated seven-year biomedical program where he received his B.A. in 1997 with honors and M.D. in 2001 with Distinction from The George Washington University, and a M.S.C.E. in genetic epidemiology from the University of Pennsylvania in 2009. Following medical school, Dr. Mehta did his internship, residency, and chief medical residency in internal medicine at the University of Pennsylvania Hospital, followed by a fellowship in cardiovascular diseases, nuclear cardiology, and preventive cardiology. Following this, he did a post-doctoral fellowship in genetic epidemiology with a focus on inflammation and lipoproteins at the University of Pennsylvania’s Center for Clinical Epidemiology and Biostatistics (CCEB) and Institute of Translational Medicine and Therapeutics (ITMAT). In 2009, Dr. Mehta joined the faculty in Cardiovascular Medicine at the University of Pennsylvania School of Medicine and at the CCEB as an Associate Scholar. Dr. Mehta came to the NIH in 2012 as the inaugural Lasker Clinical Research Scholar, joining the NHLBI’s Cardiovascular and Pulmonary Branch. In addition to the Lasker Scholarship, Dr. Mehta has received numerous local and national awards and honors, including being named a Fellow of the American College of Physicians and American Heart Association. He is actively involved in several foundations and organizations in membership and leadership capacities including the American Heart Association and National Psoriasis Foundation. He is the editor for the section on cardiovascular, metabolic, and lipoprotein translation in the Journal of Translational Medicine and serves as a reviewers for several international grant organizations as well as biomedical journals.

Last Updated: Jan 26, 2018

Program Faculty

Hafid Ait-Oufella, MD, PhD
European Georges Pompidou Hospital
Paris, France

Hafid Ait-Oufella completed his PhD in 2008 and both his internship and residency in Cardiology & Intensive Care Medicine in 2007. He was appointed to a tenured position as Associate Professor in 2010 at the Medical School, University Pierre-et-Marie Curie (Paris, France) and was promoted to full professor in 2014. He has been involved in basic, translational and clinical research for the last 15 years continuously at INSERM U689 (Lariboisière hospital, Paris) then at the INSERM U970 PARCC (European Georges Pompidou hospital) since 2009. During the last 15 years, he has trained in vascular biology and atherosclerosis, and acquired expertise in innate and adaptive immunity. Having authored more than 100 scientific papers in peer-reviewed journals, he has been actively studying the cellular and molecular pathways involved in the regulation of the immune-inflammatory response in atherosclerosis and identified a critical role for the regulatory arm of the adaptive T cell response in the control of lesion development, as well as, a previously unsuspected pathogenic role for mature B cells in the development of atherosclerosis and in post-ischemic myocardial remodelling through cooperation between B cells and monocytes.

Last Updated: Jan 23, 2019

Joel Gelfand, MD, MSCE
University of Pennsylvania, Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Dr. Gelfand is a tenured Professor of Dermatology and Epidemiology at the University of Pennsylvania’s Perelman School of Medicine. He is also Vice Chair of Clinical Research and Medical Director of the Dermatology Clinical Duties Unit, Director of the Psoriasis and Phototherapy Treatment Center, and Founding Director, of the Patient Centered Outcomes Research concentration in PENN’s graduate epidemiology master degree program. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.

Last Updated: Mar 01, 2017

Marlies Wakkee, MD, PhD
Erasmus MC University Medical Center
Rotterdam, Netherlands

I am based in Rotterdam, the Netherlands, working at the department of dermatology at the Erasmus MC as a dermatologist, mohs surgeon and senior post-doctoral researcher. I have a solid basis in epidemiology with experience in routine, population based and cancer registry data. This has resulted in completing my PhD on ‘Psoriasis, Comorbidities and Treatment’ in 2010. Since then I have continued my research in dermato‐epidemiology being part of the dermato‐epidemiology research group at the Erasmus MC and supervised PhD students in both psoriasis and skin cancer related research. I have a special interest in analyzing and interpreting large medical datasets from varying sources, which become more and more available nowadays due to the digital revolution. What I enjoy about dermato‐epidemiology is the hypothesis generating and testing aspect, which at is best leads to improving patient care.

Last Updated: Feb 04, 2019

We use cookies on this website to enhance your experience. By continuing with this website, you consent to our use of cookies. Learn more.
OK